Eye Disease Patients

Allegro Ophthalmics Has Received Approval From FDA for IND Application
Oct 11, 2013
Allegro Ophthalmics has received approval from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application to commence two Phase II clinical studies of integrin peptide therapy ALG-1001. The new trials, ...

Tags: Eye Disease Patients